课题基金 / 基金详情

A retrospective cohort study of the risk of adverse cardiovascular events following concomitant use of clopidogrel and proton pump inhibitors.

A retrospective cohort study of the risk of adverse cardiovascular events following concomitant use of clopidogrel and proton pump inhibitors.
一项关于同时使用氯吡格雷和质子泵抑制剂后不良心血管事件风险的回顾性队列研究。
批准号：
296765
负责人：
Farhat Nawal
金额：
$7.65万
依托单位：
University of Ottawa
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-10-01 至 2016-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=296765&lang=en
关键词：
Adverse Drug Reactions Cardiovascular Effects Clopidogrel Electronic Health Records Patient Safety Pharmacovigilance Proton Pump Inhibitors Regression Models Retrospective Cohort Study Secondary Health Databases

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Clopidogrel is a commonly prescribed drug used to prevent the formation of blood clots in patients with heart disease. Physicians frequently prescribe proton pump inhibitors (PPIs), a stomach acid suppressor, to prevent bleeding in the stomach and intesti
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金